Search

Search Constraints

You searched for: Author/Creator Li, R.

Search Results

4. 152P A phase I study of HBM4003, an anti-CTLA-4 heavy chain only monoclonal antibody, in combination with toripalimab in advanced melanoma. (December 2022)